Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $5.08B | $4.76B | +6.75% |
Cost of Revenue | $1.23B | $1.09B | +13.43% |
Net Income | $875.3M | $977M | -10.41% |
EPS (Basic) | $5.98 | $6.72 | -11.01% |
EPS (Diluted) | $5.97 | $6.70 | -10.90% |
SG&A Expense | $1.16B | $1.14B | +1.85% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $28.33B | $26.8B | +5.69% |
Current Assets | $7.97B | $7.11B | +12.09% |
Total Liabilities | $10.7B | $10.91B | -2.00% |
Current Liabilities | $3.18B | $3.11B | +2.43% |
Long-Term Debt | $6.28B | $6.29B | -0.13% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $420.2M | $1.18B | -64.36% |
Investing Cash Flow | $-104.3M | $400.5M | -126.04% |
Financing Cash Flow | $-34.7M | $-684.8M | +94.93% |
D&A | $377.5M | $306.4M | +23.20% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Net Margin | 17.2% | — | — |
ROA | 3.1% | — | — |
Current Ratio | $2.503 | — | — |
Other companies in Biotechnology